Clinical Trials for Elgan Pharma

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Elgan Pharma

Clinical Trials (2)

Assess the Safety of ELGN-2112 in Preterm Infants Born Under 26 Weeks GA and IUGR Infants Born 26-32 Weeks GA

PHASE2Not yet recruiting

60 participants

Started: Sep 30, 2025 · Completed: Jun 30, 2027

1 condition1 sponsor0 locations

Efficacy and Safety of ELGN-2112 on Intestinal Malabsorption in Preterm Infants

PHASE3Recruiting

360 participants

Started: Feb 20, 2025 · Completed: May 31, 2029

1 condition1 sponsor1 location